News to Know from the 20th European Congress of Rheumatology

Posted by Coping with Lupus August 11, 2019

News to Know from the 20th European Congress of Rheumatology

Last week, the Lupus Foundation of America attended the European League Against Rheumatism (EULAR) Annual Scientific Congress, which serves as a platform for the exchange of scientific and clinical advances in the field of rheumatologic diseases such as lupus. Throughout the four-day event, our Inside Lupus Research team reported on lupus treatment news and updates that matter most to people living with lupus.

At the conference, promising results from a Phase 2 study of ustekinumab in systemic lupus erythematosus (SLE) were announced, in addition to results from ongoing studies of belimumab confirming its effectiveness and ability to reduce steroid use.

Read more lupus treatment news highlights from EULAR in our recap.

Help Us Move Research Forward

Donate

The Lupus Foundation of America
2121 K Street NW Ste 200, Washington DC 20037